Teijin (TIJ) Stock Price & Analysis
TIJ Stock Chart & Stats
- Day’s Range
- EUR 9.00 - EUR 9.05
- 52-Week Range
- EUR 6.75 - EUR 9.70
- Previous Close
- EUR 9.00
- Volume
- N/A
- Average Volume (3M)
- 7
- Market Cap
- EUR 1.76B
- Enterprise Value
- EUR 502.72B
- Total Cash (Recent Filing)
- EUR 141.03B
- Total Debt (Recent Filing)
- EUR 325.24B
- Price to Earnings (P/E)
- ―
- Beta
- 0.50
- Next Earnings
- Nov 05, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 3.29%
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation
Sustained positive operating cash flow (~99B) and large free cash flow (~55B) provide durable internal funding to support operations, capex and dividends even while earnings are negative. This cash resilience lowers short-term refinancing risk and buys time to restore margins.
Diversified Specialty Businesses
A diversified mix of advanced fibers, resins, composites and healthcare services spreads end-market exposure and anchors recurring revenue. Specialty materials and downstream composites create higher-margin opportunities and customer lock-in through technical qualification and long-term OEM relationships.
Track Record Of Prior Profitability
Historical profitable performance and periods of strong margins indicate the business model can generate healthy returns when product mix, pricing or end-market demand normalize. That track record supports management's ability to rebuild margins versus a pure cyclical or structurally weak business.
Bears Say
Deteriorated Profitability
Sharp swing to sizable losses (≈-10% net margin and negative operating profits) is a lasting earnings quality concern. Persistent negative margins will erode equity, constrain reinvestment, and require sustained cash generation or corrective actions to avoid structural deterioration of competitive capabilities.
Falling Revenue Trend
Material multi-period revenue decline reduces scale economics and weakens pricing leverage for specialty products. Lower top-line volumes can magnify margin pressure through underabsorbed fixed costs and make it harder to fund R&D or qualifying cycles that sustain long-term customer relationships.
Moderate Leverage And Weakened Returns
Leverage near 0.9 combined with sharply negative ROE reduces financial flexibility. Continued losses could force higher borrowing costs or asset disposals to restore capital ratios. With only moderate cash-to-debt coverage, deleveraging will depend on sustained cash flow improvement.
Teijin News
TIJ FAQ
What was Teijin’s price range in the past 12 months?
What is Teijin’s market cap?
When is Teijin’s upcoming earnings report date?
How were Teijin’s earnings last quarter?
Is Teijin overvalued?
Does Teijin pay dividends?
What is Teijin’s EPS estimate?
How many shares outstanding does Teijin have?
What happened to Teijin’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Teijin?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Teijin
Teijin Limited, a Japanese conglomerate established in Tokyo in 1918, operates on a global scale across diverse sectors. Its core businesses encompass advanced materials, including fibers, films and sheets, and composites, as well as significant operations in healthcare and information technology. The company's materials division provides a comprehensive range of products such as high-performance aramid, carbon, and oxidized PAN fibers, along with various polyethylene materials. This segment also offers specialized items like polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. Its offerings extend to polycarbonate, high-density polyethylene porous, and microporous films and sheets, in addition to PC and polyphenylene sulfide resins, molded parts, and additives. Teijin is also a specialist in composite materials, notably developing lightweight glass and carbon fiber reinforced solutions designed for the automotive industry. In the healthcare sector, Teijin develops pharmaceuticals aimed at treating bone and joint, respiratory, and cardiovascular and metabolic diseases, among others. Furthermore, it supplies an extensive array of medical devices and services, including home oxygen therapy equipment, non-invasive positive pressure ventilation systems, rehabilitation tools, and devices for sleep-disordered breathing. The company also provides a sonic accelerated fracture healing system, community-based integrated care systems, orthopedic implantable devices, and functional food ingredients. Within its IT operations, Teijin offers innovative solutions such as Recopic, a radio-frequency identification (RFID) technology tailored for efficient inventory management. Beyond its product lines, the company is actively involved in engineering solutions, tackling critical global challenges related to environmental pollution, ensuring energy supply stability, and addressing the impact of an aging workforce population.
- Sector
- Industrials
- Industry
- Conglomerates
- CEO
- Akimoto Uchikawa
- Employees
- 15,689
- Website
- www.teijin.com
- Address
- Kasumigaseki Common Gate West Tower, Tokyo, TY, 100-8585, JP
Teijin (TIJ) Earnings & Revenues
TIJ Company Deck
TIJ Earnings Call
Earnings Call SentimentNeutral
The earnings call highlighted a positive turnaround in net income and an improved operating income forecast. However, significant challenges remain in the Materials and Healthcare segments, with operational issues in the Composites and Aramid businesses. The company faces external pressures from strikes and generic competition but is taking steps to improve profitability.
View all DE:TIJ earnings summariesTIJ Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 4 | 10 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 4 | 0 | 8 |
